Huzheng Yan
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Low-dose bevacizumab plus atezolizumab enhances transarterial chemoembolization in HCC via correcting vascular-immune niche dysfunction.
Journal: Journal of hepatology
Published: February 09, 2026
Using finite element analysis to obtain the pressure gradient between the left renal vein and the inferior vena cava: a new method for the diagnosis and follow-up of patients with nutcracker syndrome.
Journal: Quantitative imaging in medicine and surgery
Published: October 11, 2025
Transfemoral approach TACE technique in orthotopic PDX hepatocellular carcinoma models of nude rats.
Transfemoral approach TACE technique in orthotopic PDX hepatocellular carcinoma models of nude rats.
Journal: Quantitative imaging in medicine and surgery
Published: May 28, 2025
TACE Sequential to Radiofrequency Ablation versus RFA Alone in Hepatocellular Carcinoma Within Milan Criteria.
Journal: Journal of hepatocellular carcinoma
Published: May 14, 2025
Lenvatinib continuation versus regorafenib in treating hepatocellular carcinoma after lenvatinib failure.
Journal: Quantitative imaging in medicine and surgery
Published: March 10, 2025
Donafenib vs. lenvatinib combined with transarterial chemoembolization as initial therapy for unresectable hepatocellular carcinoma: a retrospective real-world study.
Journal: Quantitative imaging in medicine and surgery
Published: February 13, 2025
Evaluation of large language models in generating pulmonary nodule follow-up recommendations.
Journal: European journal of radiology open
Published: January 22, 2025
TACE Combined with Lenvatinib and Camrelizumab for Unresectable Multiple Nodular and Large Hepatocellular Carcinoma (>5 cm).
Journal: Technology in cancer research & treatment
Published: September 19, 2023
Clinical Effectiveness of Drug-Eluting Microsphere Transcatheter Arterial Chemoembolization Combined with First-Line Chemotherapy as the Initial Treatment for Patients with Unresectable Intrahepatic Cholangiocarcinoma.
Journal: Journal of vascular and interventional radiology : JVIR
Published: August 03, 2023
Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study.
Journal: Journal of hepatocellular carcinoma
Published: May 04, 2023
Idarubicin versus epirubicin in drug-eluting beads-transarterial chemoembolization for treating hepatocellular carcinoma: A real-world retrospective study.
Journal: Investigational new drugs
Published: May 01, 2023
Last Updated: 09/26/2026